EMEA-001729-PIP02-18
Key facts
| Invented name |
Oxervate
|
| Active substance |
Cenegermin
|
| Therapeutic area |
Ophthalmology
|
| Decision number |
P/0118/2019
|
| PIP number |
EMEA-001729-PIP02-18
|
| Pharmaceutical form(s) |
Eye drops, solution
|
| Condition(s) / indication(s) |
Treatment of dry eye disease
|
| Route(s) of administration |
Ocular use
|
| Contact for public enquiries |
Dompé farmaceutici S.p.A.
E-mail: annabella.amatulli@dompe.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|